Urologix, Inc. (ULGX) Reports Q3 Loss of $0.07/Share; Revs Improve

Urologix, Inc. (NASDAQ: ULGX) reported Q3 EPS of ($0.07), versus ($0.07) reported last year. Revenue for the quarter came in at $4.74 million, versus $2.98 million reported last year.

For earnings history and earnings-related data on Urologix, Inc. (ULGX) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• Wendy's U.S. president to resign, company to create COO role
• Royal Unibrew reports higher interim first-half profit as margins improve